Turner, Oliver
Novartis, Novartis Institutes for Biomedical Research, Preclinical Safety, East Hanover, NJ, USA
3 papers on CoChatORCID 0000-0003-0512-1170
Most cited papers
- Verified
Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology
Turner, O. C., Aeffner, F., Bangari, D. S., High, W., Knight, B., Forest, T., Cossic, B., Himmel, L. E., Rudmann, D. G., Bawa, B., et al. (2020) · Toxicologic Pathology
AI in cancer detectionArtificial Intelligence in Healthcare and Education
Cited by 64
- Verified
Nonclinical Safety Evaluation of scAAV8-RLBP1 for Treatment of RLBP1 Retinitis Pigmentosa
MacLachlan, T. K., Milton, M. N., Turner, O., Tukov, F., Choi, V. W., Penraat, J., Hanks, S. M., Vrouvlianis, J., Leehy, B., Li, H., et al. (2018) · Molecular Therapy - Methods & Clinical Development
Retinal Development and DisordersVirus-based gene therapy research
Cited by 40
- Verified
AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice
Choi, V. W., Bigelow, C. E., McGee, T. L., Gujar, A. N., Li, H., Hanks, S. M., Vrouvlianis, J., Maker, M., Leehy, B., Zhang, Y., et al. (2015) · Molecular Therapy - Methods & Clinical Development
Retinal Development and DisordersVirus-based gene therapy research
Cited by 35
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free